Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology(2023)

引用 2|浏览22
暂无评分
摘要
Our findings regarding the heterogeneity in outcomes for patients with dnMBC could guide future revisions of the current American Joint Committee on Cancer staging guidelines for patients with newly diagnosed stage IV disease. Our findings should be independently confirmed.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要